Proceedings of the 27th Annual Congress of the International Liver Transplantation Society.
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
01 06 2023
01 06 2023
Historique:
medline:
25
5
2023
pubmed:
23
5
2023
entrez:
23
5
2023
Statut:
ppublish
Résumé
After a virtual congress in 2021 and a previous absence in 2020 because of the coronavirus disease 2019 pandemic, the 27th Annual Congress of the International Liver Transplantation Society was held from May 4 to 7, 2022, in a hybrid format in Istanbul, with 1123 (58% on-site) liver transplant professionals from 61 countries attending the meeting. The hybrid format successfully achieved a balance of much yearned-for "in-person interaction" and global online participation. Almost 500 scientific abstracts were presented. In this report, the Vanguard Committee aims to present a summary of key invited lectures and selected abstracts for the liver transplant community.
Identifiants
pubmed: 37220340
doi: 10.1097/TP.0000000000004637
pii: 00007890-202306000-00005
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1226-1231Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Bhat M, Dondossola D, Varghese R, et al. What is hot and new in basic and translational science in liver transplantation in 2022? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society. Transplantation. 2022;107:808–814.
Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405–414.
Linecker M, Stavrou GA, Oldhafer KJ, et al. The ALPPS Risk Score: avoiding futile use of ALPPS. Ann Surg. 2016;264:763–771.
Melandro F, Giovanardi F, Hassan R, et al. Minimally invasive approach in the setting of ALPPS procedure: a systematic review of the literature. J Gastrointest Surg. 2019;23:1917–1924.
Boning G, Fehrenbach U, Auer TA, et al. Liver venous deprivation (LVD) versus portal vein embolization (PVE) alone prior to extended hepatectomy: a matched pair analysis. Cardiovasc Intervent Radiol. 2022;45:950–957.
Chebaro A, Buc E, Durin T, et al. Liver venous deprivation or associating liver partition and portal vein ligation for staged hepatectomy?: a retrospective multicentric study. Ann Surg. 2021;274:874–880.
Han HS, Cho JY, Kaneko H, et al. Expert panel statement on laparoscopic living donor hepatectomy. Dig Surg. 2018;35:284–288.
Cherqui D, Ciria R, Kwon CHD, et al. Expert Consensus Guidelines on minimally invasive donor hepatectomy for living donor liver transplantation from innovation to implementation: a joint initiative from the International Laparoscopic Liver Society (ILLS) and the Asian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA). Ann Surg. 2021;273:96–108.
Rela M, Rajalingam R, Shetty G, et al. Robotic monosegment donor hepatectomy for pediatric liver transplantation: first report. Pediatr Transplant. 2022;26:e14110.
Colmenero J, Rodriguez-Peralvarez M, Salcedo M, et al. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol. 2021;74:148–155.
Campos-Varela I, Dodge JL, Berenguer M, et al. Temporal trends and outcomes in liver transplantation for recipients with HIV infection in Europe and United States. Transplantation. 2020;104:2078–2086.
Campos-Varela I, Dodge JL, Terrault NA, et al. Non-viral liver disease is the leading indication for liver transplant in the U.S. in persons living with human immunodeficiency virus. Am J Transplant. 2021;21:3148–3156.
Dominguez-Gil B, Moench K, Watson C, et al. Prevention and management of donor-transmitted cancer after liver transplantation: guidelines from the ILTS-SETH Consensus Conference. Transplantation. 2022;106:e12–e29.
Durand F, Levitsky J, Cauchy F, et al. Age and liver transplantation. J Hepatol. 2019;70:745–758.
Steggerda JA, Bloom MB, Noureddin M, et al. Higher thresholds for the utilization of steatotic allografts in liver transplantation: analysis from a U.S. national database. PLoS One. 2020;15:e0230995.
Yoon YI, Song GW, Lee SG, et al. Safe use of right lobe living donor livers with moderate steatosis in adult-to-adult living donor liver transplantation: a retrospective study. Transplant Inter. 2021;34:872–881.
VanDerwerken DN, Wood NL, Segev DL, et al. The precise relationship between model for end-stage liver disease and survival without a liver transplant. Hepatology. 2021;74:950–960.
Godfrey EL, Malik TH, Lai JC, et al. The decreasing predictive power of MELD in an era of changing etiology of liver disease. Am J Transplant. 2019;19:3299–3307.
Belli LS, Duvoux C, Artzner T, et al.; ELITA/EF-CLIF working group. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS). J Hepatol. 2021;75:610–622.
Lai JC, Tandon P, Bernal W, et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the american association for the study of liver diseases. Hepatology. 2021;74:1611–1644.
Artru F, le Goffic C, Pageaux GP, et al. Sarcopenia should be evaluated in patients with acute-on-chronic liver failure and candidates for liver transplantation. J Hepatol. 2022;76:983–985.
Alqahtani SA, Schneider C, Sims OT, et al. Liver transplantation for Budd-Chiari syndrome in the MELD era. Transplant Direct. 2022;8:e1407.
Fontana RJ, Stravitz RT, Durkalski V, et al. Prognostic value of the (13) C-methacetin breath test in adults with acute liver failure and non-acetaminophen acute liver injury. Hepatology. 2021;74:961–972.
Yoon YI, Lim JH, Lee SG, et al. Role of extracorporeal membrane oxygenation as a salvage therapy for liver transplantation recipients in a high-volume transplant center. Liver Transplant. 2023;29:67–79.
Kutkut I, Rachwan RJ, Timsina LR, et al. Pre-liver transplant cardiac catheterization is associated with low rate of myocardial infarction and cardiac mortality. Hepatology. 2020;72:240–256.
Bangalore S, Maron DJ, Stone GW, et al. Routine revascularization versus initial medical therapy for stable ischemic heart disease: a systematic review and meta-analysis of randomized trials. Circulation. 2020;142:841–857.
Gao Q, Anwar IJ, Abraham N, et al. Liver transplantation for hepatocellular carcinoma after downstaging or bridging therapy with immune checkpoint inhibitors. Cancers (Basel). 2021;13:6307.
Lewandowski RJ, Kulik LM, Riaz A, et al. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. American J Transplant. 2009;9:1920–1928.
Salem R, Lewandowski RJ, Kulik L, et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology. 2011;140:497–507.e2.
Demetris AJ, Bellamy C, Hubscher SG, et al. 2016 Comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection. American J Transplant. 2016;16:2816–2835.
Feng S, Bucuvalas JC, Mazariegos GV, et al. Efficacy and safety of immunosuppression withdrawal in pediatric liver transplant recipients: moving toward personalized management. Hepatology. 2021;73:1985–2004.
Vionnet J, Miquel R, Abraldes JG, et al. Non-invasive alloimmune risk stratification of long-term liver transplant recipients. J Hepatol. 2021;75:1409–1419.
Benitez C, Londono MC, Miquel R, et al. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology. 2013;58:1824–1835.
Aguilera V, Andacoglu O, Francoz C, et al. Gender and racial disparity among liver transplantation professionals: report of a global survey. Transplant Inter. 2022;35:10506.